255 related articles for article (PubMed ID: 29805067)
1. The synergistic effects of IL-6/IL-17A promote osteogenic differentiation by improving OPG/RANKL ratio and adhesion of MC3T3-E1 cells on hydroxyapatite.
Sritharan S; Kannan TP; Norazmi MN; Nurul AA
J Craniomaxillofac Surg; 2018 Aug; 46(8):1361-1367. PubMed ID: 29805067
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A promotes osteogenic differentiation by increasing OPG/RANKL ratio in stem cells from human exfoliated deciduous teeth (SHED).
Sebastian AA; Kannan TP; Norazmi MN; Nurul AA
J Tissue Eng Regen Med; 2018 Aug; 12(8):1856-1866. PubMed ID: 29774992
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
Liu XH; Kirschenbaum A; Yao S; Levine AC
Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
[TBL] [Abstract][Full Text] [Related]
5. Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.
Lee DW; Kwon JY; Kim HK; Lee HJ; Kim ES; Kim HJ; Kim HJ; Lee HB
Int J Med Sci; 2018; 15(7):723-729. PubMed ID: 29910677
[TBL] [Abstract][Full Text] [Related]
6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
7. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells.
Li F; Yang Y; Zhu P; Chen W; Qi D; Shi X; Zhang C; Yang Z; Li P
Fitoterapia; 2012 Dec; 83(8):1443-50. PubMed ID: 22951288
[TBL] [Abstract][Full Text] [Related]
8. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
Lavocat F; Osta B; Miossec P
Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
[TBL] [Abstract][Full Text] [Related]
10. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients].
Xu Y; Ya XP; Zhang WJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):521-4. PubMed ID: 22803436
[TBL] [Abstract][Full Text] [Related]
11. Icariin Stimulates hFOB 1.19 Osteoblast Proliferation and Differentiation via OPG/RANKL Mediated by the Estrogen Receptor.
Sun LJ; Li C; Wen XH; Guo L; Guo ZF; Liao LQ; Guo Y
Curr Pharm Biotechnol; 2021; 22(1):168-175. PubMed ID: 31971108
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin.
Ren G; Wang K; Chang R; Su Y; Wang J; Su J; Han B
Biol Trace Elem Res; 2011 Dec; 144(1-3):1437-48. PubMed ID: 21739163
[TBL] [Abstract][Full Text] [Related]
13. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH
Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675
[TBL] [Abstract][Full Text] [Related]
14. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
[TBL] [Abstract][Full Text] [Related]
15. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line.
Ren H; Ren H; Li X; Yu D; Mu S; Chen Z; Fu Q
Mol Med Rep; 2015 Nov; 12(5):6711-7. PubMed ID: 26398911
[TBL] [Abstract][Full Text] [Related]
16. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
18. Effect of technetium-99 conjugated with methylene diphosphonate (
Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
[TBL] [Abstract][Full Text] [Related]
19. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
Coetzee M; Haag M; Kruger MC
J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
[TBL] [Abstract][Full Text] [Related]
20. Phosphocreatine Promotes Osteoblastic Activities in H
Jing Z; Wang C; Wen S; Jin Y; Meng Q; Liu Q; Wu J; Sun H; Liu M
Curr Pharm Biotechnol; 2021; 22(5):609-621. PubMed ID: 33198615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
